Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: Autopsy study and review of the literature

Stroke

Volumn 32, Issue 11, 2001, Pages 2481-2485

  Conway, James E ^a   Hutchins, Grover M ^a   Tamargo, Rafael J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aneurysm; Autopsy; Neurofibromatosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRACRANIAL ANEURYSM; MALE; NEUROFIBROMATOSIS; PREVALENCE; PRIORITY JOURNAL; COMPARATIVE STUDY; PATHOLOGY; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FEMALE; HUMAN; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGE; NEUROFIBROMATOSIS 1; PREVALENCE;

EID: 0035160564     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1101.098329     Document Type: Article

References (60)

1. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
2. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
3. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients
4. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
5. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
6. Identification of the neurofibromatosis type 1 gene product
7. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
8. The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin
9. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development
10. Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin
11. Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle
12. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17
13. Progress towards the isolation and characterization of the genes causing neurofibromatosis
14. Somatic deletion of the neurofibromatosis type I gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
15. Von Recklinghausen neurofibromatosis: A clinical and population study in south-east Wales
16. Identification of NF1 mutations in both alleles of a dermal neurofibroma
17. Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: A case report
18. Von Recklinghausen's disease: A clinicopathological study
19. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms
20. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1: A twelve-year follow-up of an epidemiological study in Goteborg, Sweden
21. Neurological complications of neurofibromatosis type 1 in adulthood
22. A clinical study of type 1 neurofibromatosis in north west England
23. A propos des anevrysmes des arteres cerebrales associes a d'autres malformations
24. Pheochromocytoma associated with multiple neurofibromatosis and aneurysm of circle of Willis
25. Renovaskulare hypertension bei neurofibromatosis
26. Multiple arterial lesions in von Recklinghausen's disease: A case
27. Neurofibromatosis associated with intra- and extracranial aneurysms and extracranial vertebral arteriovenous fistula
28. Non-atheromatous stenosis and occlusion of the internal carotid artery and its main branches
29. Neurofibromatosis with extensive intracranial arterial occlusive disease
30. Recklinghausen's disease associated with occlusion of bilateral middle cerebral artery, moyamoya phenomenon, and anterior communicating artery aneurysm: Report of an autopsy case
31. Multiple intracranial aneurysms in relation to Recklinghausen's disease: Report of a case
32. Cerebral aneurysms associated with neurofibromatosis
33. Asymptomatic fusiform aneurysm of the petrous carotid artery in a patient with von Recklinghausen's neurofibromatosis
34. Intracranial fusiform aneurysms in von Recklinghausen's disease: Case report and literature review
35. Cerebral aneurysm associated with von Recklinghausen's neurofibromatosis: A case report
36. Neurofibromatosis associated with moyamoya arteriopathy and fusiform aneurysm: Case report
37. Two cases of subarachnoid hemorrhage associated with neurofibromatosis type I: A case of multiple cerebral aneurysms and arteriovenous malformation, and another case of an anterior communicating artery aneurysm
38. Cerebral aneurysms associated with von Recklinghausen neurofibromatosis: Report of two cases
39. Multiple intracranial aneurysms and neurofibromatosis: A case report
40. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
41. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis
42. Risk factors for the development and rupture of intracranial berry aneurysms
43. The familial occurrence of intracranial aneurysms
44. Neurofibromatse et lesions vasculaires
45. Primary cerebral arterial occlusive disease in children, II: Neurocutaneous syndromes
46. Neurovascular manifestations of heritable connective tissue disorders: A review
47. Genetics of intracranial aneurysms
48. Marfan syndrome is not associated with intracranial aneurysms
49. Neurofibromatosis: A clinical and genetic study of 96 cases in Gothenburg, Sweden
50. Linkage analysis of neurofibromatosis
51. Upper airway obstruction in neurofibromatosis
52. Periampullary neoplasms in von Recklinghausen's disease
53. Neurofibromatosis 1: Recognition and management of associated neuroblastoma
54. Familial neurofibromatosis type 1: Clinical experience with DNA testing
55. Diffusion of information about neurofibromatosis type 1 DNA testing
56. Neurofibromatosis type 1: The cognitive phenotype
57. Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities
58. Aneurysmal subarachnoid hemorrhage: Prognostic features and outcomes